Coverage
-
May 10, 2016
Direct and indirect purchasers of the contraceptive Loestrin filed amended complaints in Rhode Island federal court Monday in the pay-for-delay multidistrict litigation against Warner Chilcott Ltd., newly alleging that the drug giant engaged in a product-hopping scheme to exclude competitors from the relevant market.
1 other articles on this case.
View all »